Physician profile
Judith Uphold
NPI 1699189662
$5,808.92
in general payments reported to CMS, 2019-2025
17 companies · $825 in 2025
The $825 reported for 2025 was more than what 88% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $55.99 · 2020: $13.31 · 2021: $318 · 2022: $2,071 · 2023: $822 · 2024: $1,703 · 2025: $825.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,416 · Travel and Lodging: $935.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,415.89 |
| Travel and Lodging | $934.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,850.00 | 2021-2025 | Precision7, Precision 1, Tryptyr |
| Biotissue Holdings INC. | $1,648.33 | 2021-2025 | |
| Bausch & Lomb Americas INC. | $638.67 | 2022-2025 | Miebo, Xiidra, Vyzulta |
| Tarsus Pharmaceuticals, INC. | $405.39 | 2024-2025 | Xdemvy |
| Novartis Pharmaceuticals Corporation | $365.44 | 2019-2023 | |
| Sun Pharmaceutical Industries INC. | $271.91 | 2021-2025 | Cequa |
| Coopervision INC. | $254.10 | 2019-2025 | Clariti Contact Lens, Myday Contact Lens |
| Allergan, INC. | $89.41 | 2021 | |
| Lkc Technologies, INC. | $71.99 | 2024 | |
| Harrow Eye, LLC | $37.51 | 2024 | Vevye |
| Oyster Point Pharma, INC. | $37.39 | 2022-2025 | Tyrvaya, Ryzumvi |
| Dompe US, INC. | $35.27 | 2022-2025 | Oxervate |
| Abbvie INC. | $33.70 | 2022 | |
| Shire North American Group INC | $23.33 | 2019 | |
| Kala Pharmaceuticals, INC. | $16.52 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eyevance Pharmaceuticals LLC | $16.35 | 2022 | |
| Thea Pharma INC. | $13.61 | 2024 | Iyuzeh |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Judith Uphold listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.